Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2021

View Archived Issues

Novel series of 5,5-fused bicyclic PRMT5 inhibitors as potential anticancer therapeutics

Phase II results of suvratoxumab to prevent S. aureus ventilator-associated pneumonia

C4 selects CFT-8919 for progression into IND-enabling studies

The University of Pennsylvania describes fibronectin-targeting chimeric antigen receptors

AXL oncogene inhibitors discovered at Jiangsu Chia Tai Tianqing Pharmaceutical Group

Dual GLP-1/GCGR agonists synthesized at Dongguan Hec Biological Medicine Research & Development

Oncobix divulges mutant ALK/mutant EGFR inhibitors

REVOLUTION Medicines patents RAS inhibitors

Beclin-1 implicated in diabetic cardiomyopathy

FDA accepts IND application for LY-3819469

Oncorus announces development plans for its novel synthetic vRNA immunotherapy candidates

Gene signature governs anti-plaque microglia in AD

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

Activation of MT2 reduces cardiac I/R injury in prediabetic rats

Topical bevacizumab-800CW is safe for detecting esophageal lesions during NIR-FME

OSE's COVID-19 vaccine CoVepiT enters first-in-human study

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

New biomarkers found to monitor disease progression in eosinophilic esophagitis

Preclinical data show AdCOVID neutralizes SARS-CoV-2 B.1.351 variant

Cystic Fibrosis Foundation awards support research at Metagenomi and Eloxx

AGT103-T HIV therapeutic enters first-in-human study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...